PEGylation of bovine serum albumin using click chemistry for the application as drug carriers

Biotechnology Progress

Volumn 28, Issue 3, 2012, Pages 856-861

  Li, Xiao Yuan ^a   Li, Tai Hang ^a,b   Guo, Jin Shan ^a   Wei, Ying ^a,b   Jing, Xia Bin ^a   Chen, Xue Si ^a   Huang, Yu Bin ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

5 fluorouracil; Bovine serum albumin; Click chemistry; Drug carriers; MPEG; Rifampicin

Indexed keywords

5-FLUOROURACIL; BOVINE SERUM ALBUMINS; CLICK CHEMISTRY; DRUG CARRIER; MPEG; RIFAMPICIN;

ACETYLENE; ADSORPTION; BIOACTIVITY; BIOCOMPATIBILITY; BODY FLUIDS; CIRCULAR DICHROISM SPECTROSCOPY; CYCLOADDITION; MAMMALS; POLYETHYLENE GLYCOLS; SYNTHESIS (CHEMICAL);

MOTION PICTURE EXPERTS GROUP STANDARDS;

BOVINE SERUM ALBUMIN; DRUG CARRIER; FLUOROURACIL; MACROGOL DERIVATIVE; RIFAMPICIN;

ARTICLE; CHEMISTRY; CIRCULAR DICHROISM; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

CIRCULAR DICHROISM; DRUG CARRIERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUOROURACIL; MAGNETIC RESONANCE SPECTROSCOPY; POLYETHYLENE GLYCOLS; RIFAMPIN; SERUM ALBUMIN, BOVINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

BOVINAE;

EID: 84862787417     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1526     Document Type: Article

References (41)

1. Sofia SJ, Merill EW. Poly(ethylene glycol): Chemistry and Biological Applications. Washington, DC: American Chemical Society; 1997.
2. Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem. 1977; 252: 3578-3581.
3. Abuchowski A, McCoy JR, Palczuk NC, Van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem. 1977; 252: 3582-3586.
4. Veronese FM, Morpurgo M. Bioconjugation in pharmaceutical chemistry. Farmaco. 1999; 54: 497-516.
5. Monfardini C, Veronese FM. Stabilization of substances in circulation. Bioconjugate Chem. 1998; 9: 418-450.
6. Nucci ML, Shorr R, Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Deliv Rev. 1991; 6: 133-151.
7. Maeda H. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev. 2001; 46: 169-185.
8. Sehon AH. Suppression of antibody responses by conjugates of antigens and monomethoxy poly(ethylene glycol). Adv Drug Deliv Rev. 1991; 6: 203-217.
9. Wu L, Martin CG, Etienne S, Stanley SD, Lisbeth I. Preparation and in vitro characterization of HSA-mPEG nanoparticles. Int J Pharm. 1999; 189: 161-170.
10. 2-transporting ability. Bioconjugate Chem. 2006; 17: 393-398.
11. Ton NC, Parker GJ, Jackson A, Mullamitha S, Buonaccorsi GA, Roberts C, Watson Y, Davies K, Cheung S, Hope L, Power F, Lawrance J, Valle J, Saunders M, Felix R, Soranson JA, Rolfe L, Zinkewich-Peotti K, Jayson GC. Phase I evaluation of CDP791, a PEGylated di-Fab′ conjugate that binds vascular endothelial growth factor receptor 2. Clin Cancer Res. 2007; 13: 7113-7118.
12. Loquai C, Nashan D, Hensen P, Luger TA, Grabbe S, Sunderkötter C, Schiller M. Safety of pegylated interferon-alpha-2a in adjuvant therapy of intermediate and high-risk melanomas. Eur J Dermatol. 2008; 18: 29-35.
13. Green MD, Koelbl H, Baselga J, Galid A, Guillem V, Gascon P, Siena S, Lalisang RI, Samonigg H, Clemens MR, Zani V, Liang BC, Renwick J, Piccart MJ. A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol. 2003; 14: 29-35.
14. Moskowitz CH, Hamlin PA, Gabrilove J, Bertino JR, Portlock CS, Straus DJ, Gencarelli AN, Nimer SD, Zelenetz AD. Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma. Ann Oncol. 2007; 18: 1842-1850.
15. Pasut G, Veronese FM. PEG conjugates in clinical development or use as anticancer agents: an overview. Adv Drug Deliv Rev. 2009; 61: 1177-1188.
16. Zophel L, Eisele K, Gropeanu R, Rouhanipour A, Koynov K, Lieberwirth I, Mullen K, Weil TJ. Preparation of defined albumin-polymer hybrids for efficient cell transfection. Macromol Chem Phys. 2010; 211: 146-153.
17. Li M, De P, Gondi SR, Sumerlin BS. Responsive polymer-protein bioconjugates prepared by RAFT polymerization and copper catalyzed azide-alkyne click chemistry. Macromol Rapid Commun. 2008; 29: 1172-1176.
18. Dirks AT, Cornelissen JJ, Nolte RJ. Monitoring protein-polymer conjugation by a fluorogenic Cu(I)-catalyzed azide-alkyne 1, 3-dipolar cycloaddition. Bioconjugate Chem. 2009; 20: 1129-1138.
19. Zarafshani Z, Obata T, Lutz JF. Smart PEGylation of trypsin. Biomacromolecules. 2010; 11: 2130-2135.
20. Dimonie M, Teodorescu M. Phase transfer catalysis synthesis of α, ω-diallylpoly(ethylene oxide). Makromol Chem Rapid Commun. 1993; 14: 303-307.
21. Kostanski JW, DeLuca PP. A novel in vitro release technique for peptide-containing biodegradable microspheres. AAPS PharmSciTech. 2000; 1: 30-40.
22. Shi Q, Chen XS, Lu TC, Jing XB. The immobilization of proteins on biodegradable polymer fibers via click chemistry. Biomaterials. 2008; 29: 1118-1126.
23. Lutz JF, Borner HG, Weichenhan K. 'Click' bioconjugation of a well-defined synthetic polymer and a protein transduction domain. Aust J Chem. 2007; 60: 410-413.
24. Rykke M, Young A, Smistad G, Rolla G, Karlsen J. Zeta potentials of human salivary micelle-like particles. Colloids Surf B. 1996; 6: 51-56.
25. Uskokovic V, Castiglione Z, Cubas P, Zhu L, Li W, Habelitz S. Zeta-potential and particle size analysis of human amelogenins. J Dent Res. 2010; 89: 149-153.
26. 99mTechnetium-fluconazole nanocapsules. Int J Pharm. 2008; 349: 152-160.
27. Shi B, Fang C, Pei YY. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J Pharm Sci. 2006; 95: 1873-1887.
28. Heredia KL, Maynard HD. Synthesis of protein-polymer conjugates. Org Biomol Chem. 2007; 5: 45-53.
29. Nemethy G, Scheraga HA. The structure of water and hydrophobic bonding in proteins. III. The thermodynamic properties of hydrophobic bonds in proteins. J Phys Chem. 1962; 66: 1773-1789.
30. Timasheff SN. Thermodynamics of Protein Interactions: Proteins of Biological Fluids. Oxford: Pergamon Press; 1972: 511-519.
31. Ross PD, Subramanian S. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry. 1981; 20: 3096-3102.
32. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature. 1992; 358: 209-215.
33. Liu JQ, Tian JN, Xie JP, Bian QQ, Hu ZD. Research on interaction of magnolol with human serum albumin. Chin J Anal Chem. 2006; 34: 557-560.
34. Lin J, Zhao W, Ding F, Jiang ZQ. Thermochemical studies on the reaction of barbital sodium with bovine serum albumin. Spectrosc Spect Anal. 2008; 28: 648-651.
35. Lin W, Garnett MC, Davis SS, Schacht E, Ferruti P, Illum L. Preparation and characterization of rose Bengal-loaded surface-modified albumin nanoparticles. J Controlled Release. 2001; 71: 117-126.
36. Santhi K, Dhanaraj SA, Joseph V, Ponnusankar S, Suresh B. A study on the preparation and anti-tumor efficacy of bovine serum albumin nanospheres containing 5-fluorouracil. Drug Dev Ind Pharm. 2002; 28: 1171-1179.
37. Peracchia MT, Gref R, Minamitake Y, Domb A, Lotan N, Langer R. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics. J Controlled Release. 1997; 46: 223-231.
38. Zhang J, Fan XD, Liu YF, Bo L, Liu X. Synthesis of poly(ethylene glycol)-metaxalone conjugates and study of its controlled release in vitro. Int J Pharm. 2007; 332: 125-131.
39. Liu JQ, Tian JN, Tian X, Hu ZD, Chen XG. Interaction of isofraxidin with human serum albumin. Bioorg Med Chem. 2004; 12: 469-474.
40. Wangoo N, Suri CR, Shekhawat G. Interaction of gold nanoparticles with protein: a spectroscopic study to monitor protein conformational changes. Appl Phys Lett. 2008; 92: 133104/1-3.
41. Brandes N, Welzel PB, Werner C, Kroh LW. Adsorption-induced conformational changes of proteins onto ceramic particles: differential scanning calorimetry and FTIR analysis. J Colloid Interface Sci. 2006; 299: 56-69.